难治/复发性 refractory or relapse
难治复发性急性白血病 RRAL
难治及复发性 Refractory and relapse
复发难治性淋巴瘤 recurrent and refractory lymphoma
This study was to evaluate the efficacy of DACE regimen, as a salvage regimen, on relapsed and refractory NHL, and observe the adverse events.
本研究旨在观察DACE方案治疗难治复发性非霍奇金淋巴瘤的治疗疗效及毒副作用。
参考来源 - DACE方案治疗难治复发性非霍奇金淋巴瘤的临床疗效·2,447,543篇论文数据，部分数据来源于NoteExpress
氯法拉滨注射液适用于对至少2种治疗方案无效的儿童(1 - 21岁)难治性或复发性急性淋巴细胞白血病的治疗。
Clofarabine injection is indicated for the treatment of pediatric patients (ages 1-21 years) with relapsed or refractory acute lymphoblastic leukemia after at least 2 previous regimens.
研究复发性、难治性中高度恶性非霍奇金淋巴瘤的解救治疗。
To study the salvage treatment of relapsed or refractory intermediate-high aggressive non-Hodgkin lymphoma (NHL).
目的：研究MOD方案对难治性、复发性多发性骨髓瘤(MM)的疗效和毒性反应。
Objective to study the effect and toxicity of MOD regimen in treatment of refractory or recurrent multiple myeloma (MM).
应用推荐